Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Bisphosphonate, denosumab not linked to acute cardiovascular risk
Use of oral bisphosphonate or denosumab does not appear to increase the risk of cardiovascular events (CVEs), namely acute myocardial infarction, unstable angina, cerebrovascular accident, and transient ischemic attack, in persons with incident fracture, a study has shown.
Bisphosphonate, denosumab not linked to acute cardiovascular risk
06 May 2023
Preconception HBV history linked to congenital heart disease risk in offspring
Children born to mothers who had contracted hepatitis B virus (HBV) infection before pregnancy appear to be at increased risk of congenital heart diseases (CHDs), as reported in a study.
Preconception HBV history linked to congenital heart disease risk in offspring
04 May 2023
Is hypotension avoidance better than hypertension avoidance in noncardiac surgery?
The incidence of major vascular complications among patients who underwent noncardiac surgery is similar between hypotension- and hypertension-avoidance strategies, reports a study.
Is hypotension avoidance better than hypertension avoidance in noncardiac surgery?
04 May 2023
Poor awareness of hypertension self-management practices persists: study
A recent study conducted in Nigeria from December 2019 to February 2020 has revealed many individuals with little to no awareness of hypertension self-management practices.
Poor awareness of hypertension self-management practices persists: study
03 May 2023
NOACs proven safe, effective in Asians with AF
Use of nonvitamin K antagonist oral anticoagulants (NOACs) helps prevent thromboembolic events in Asian patients with atrial fibrillation (AF), with fewer bleeding events relative to warfarin therapy, according to the results of a study presented at the recent EHRA 2023.